A Phase III Study of Entecavir vs Lamivudine in Adults With Chronic Hepatitis B Infection and Negative for Hepatitis B e Antigen
Public ClinicalTrials.gov record NCT00035789. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Study identification
- NCT ID
- NCT00035789
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Bristol-Myers Squibb
- Industry
- Enrollment
- Not listed
Conditions and interventions
Conditions
Interventions
- Entecavir Drug
Drug
Eligibility (public fields only)
- Age range
- 16 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 31, 2001
- Primary completion
- Apr 30, 2005
- Completion
- Apr 30, 2005
- Last update posted
- Apr 13, 2011
2001 – 2005
United States locations
- U.S. sites
- 31
- U.S. states
- 23
- U.S. cities
- 31
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Local Investigator | Birmingham | Alabama | — | — |
| Local Investigator | Tucson | Arizona | — | — |
| Local Investigator | La Jolla | California | — | — |
| Local Investigator | Los Angeles | California | 90048 | — |
| Local Investigator | Orange | California | — | — |
| Local Investigator | San Francisco | California | — | — |
| Local Investigator | Farmington | Connecticut | — | — |
| Local Investigator | Miami Beach | Florida | — | — |
| Local Investigator | Atlanta | Georgia | 30322 | — |
| Local Investigator | Honolulu | Hawaii | — | — |
| Local Investigator | Chicago | Illinois | 60622 | — |
| Local Investigator | Iowa City | Iowa | — | — |
| Local Investigator | Kansas City | Kansas | — | — |
| Local Investigator | Dundalk | Maryland | — | — |
| Local Investigator | Worcester | Massachusetts | — | — |
| Local Investigator | Ann Arbor | Michigan | — | — |
| Local Investigator | Royal Oak | Michigan | — | — |
| Local Investigator | Saint Paul | Minnesota | — | — |
| Local Investigator | Manhasset | New York | — | — |
| Local Investigator | New York | New York | — | — |
| Local Investigator | Rochester | New York | — | — |
| Local Investigator | Charlotte | North Carolina | — | — |
| Local Investigator | Cleveland | Ohio | — | — |
| Local Investigator | Philadelphia | Pennsylvania | — | — |
| Local Investigator | Pittsburgh | Pennsylvania | — | — |
| Local Investigator | Providence | Rhode Island | — | — |
| Local Investigator | Nashville | Tennessee | 37211 | — |
| Local Investigator | Dallas | Texas | — | — |
| Local Investigator | Fairfax | Virginia | — | — |
| Local Investigator | Richmond | Virginia | — | — |
| Local Investigator | Seattle | Washington | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00035789, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 13, 2011 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00035789 live on ClinicalTrials.gov.